Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza A Mouse Model
Fucoidans are known to be effective inhibitors of inflammation, and of virus binding and cellular entry. <i>Undaria pinnatifida</i>-derived fucoidan (UPF) was assessed in a severe influenza A (H1N1, PR8) infection model in mice. Initially, UPF was gavaged at 3.52 mg daily in a treatment...
Main Authors: | Claire Richards, Neil A. Williams, J. Helen Fitton, Damien N. Stringer, Samuel S. Karpiniec, Ah Young Park |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/18/5/246 |
Similar Items
-
Fucoidan and Lung Function: Value in Viral Infection
by: J. Helen Fitton, et al.
Published: (2020-12-01) -
Therapies from Fucoidan: New Developments
by: J. Helen Fitton, et al.
Published: (2019-10-01) -
Therapies from Fucoidan; Multifunctional Marine Polymers
by: Janet Helen Fitton
Published: (2011-09-01) -
Fucoidan Independently Enhances Activity in Human Immune Cells and Has a Cytostatic Effect on Prostate Cancer Cells in the Presence of Nivolumab
by: Ah Young Park, et al.
Published: (2021-12-01) -
Therapies from Fucoidan: An Update
by: Janet Helen Fitton, et al.
Published: (2015-09-01)